en Experimental Neurobiology

Cited by CrossRef (53)

  1. Kun Cheng Liu, Yuan Guo, Jin Zhang, Li Chen, Yi Wei Liu, Shu Xuan Lv, Wen Xie, Hui Sheng Wang, Yu Ming Zhang, Li Zhang. Activation and blockade of dorsal hippocampal Serotonin6 receptors regulate anxiety-like behaviors in a unilateral 6-hydroxydopamine rat model of Parkinson’s disease. Neurological Research 2019;41:791
    https://doi.org/10.1080/01616412.2019.1611204
  2. Margarita A. Morozova, Taisiya A. Lepilkina, Georgy E. Rupchev, Allan G. Beniashvily, Denis S. Burminskiy, Sergey S. Potanin, Evgeny V. Bondarenko, Vasily I. Kazey, Yan Lavrovsky, Alexandre V. Ivachtchenko. Add-on clinical effects of selective antagonist of 5HT6 receptors AVN-211 (CD-008-0173) in patients with schizophrenia stabilized on antipsychotic treatment: pilot study. CNS Spectr. 2014;19:316
    https://doi.org/10.1017/S1092852913000394
  3. Daniela Galimberti, Elio Scarpini. Idalopirdine as a treatment for Alzheimer’s disease. Expert Opinion on Investigational Drugs 2015;24:981
    https://doi.org/10.1517/13543784.2015.1052402
  4. Soon-Hee Kim, Misun Seo, Hongik Hwang, Dong-Min Moon, Gi Hoon Son, Kyungjin Kim, Hyewhon Rhim. Physical and Functional Interaction between 5-HT6 Receptor and Nova-1. Exp Neurobiol 2019;28:17
    https://doi.org/10.5607/en.2019.28.1.17
  5. . The Role of 5-HT Systems on Memory and Dysfunctional Memory. 2019.
    https://doi.org/10.1016/B978-0-12-800836-2.00022-2
  6. Agnieszka Zagórska, Anna Jaromin. Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy. Molecules 2020;25:3337
    https://doi.org/10.3390/molecules25153337
  7. Patryk Pyka, Wawrzyniec Haberek, Małgorzata Więcek, Ewa Szymanska, Wesam Ali, Agnieszka Cios, Magdalena Jastrzębska-Więsek, Grzegorz Satała, Sabina Podlewska, Silvia Di Giacomo, Antonella Di Sotto, Sabrina Garbo, Tadeusz Karcz, Chiara Lambona, Francesco Marocco, Gniewomir Latacz, Sylwia Sudoł-Tałaj, Barbara Mordyl, Monika Głuch-Lutwin, Agata Siwek, Kinga Czarnota-Łydka, Dawid Gogola, Agnieszka Olejarz-Maciej, Natalia Wilczyńska-Zawal, Ewelina Honkisz-Orzechowska, Małgorzata Starek, Monika Dąbrowska, Katarzyna Kucwaj-Brysz, Rossella Fioravanti, Muhammad Jawad Nasim, Marius Hittinger, Anna Partyka, Anna Wesołowska, Cecilia Battistelli, Clemens Zwergel, Jadwiga Handzlik. First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer’s Disease. J. Med. Chem. 2024;67:1580
    https://doi.org/10.1021/acs.jmedchem.3c02148
  8. Marie Spies, Patricia Anna Handschuh, Rupert Lanzenberger, Georg S. Kranz. Sex Differences in Neurology and Psychiatry. 2024.
    https://doi.org/10.1016/B978-0-444-64123-6.00009-6
  9. Anna Więckowska, Marcin Kołaczkowski, Adam Bucki, Justyna Godyń, Monika Marcinkowska, Krzysztof Więckowski, Paula Zaręba, Agata Siwek, Grzegorz Kazek, Monika Głuch-Lutwin, Paweł Mierzejewski, Przemysław Bienkowski, Halina Sienkiewicz-Jarosz, Damijan Knez, Tomasz Wichur, Stanislav Gobec, Barbara Malawska. Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT 6 receptor antagonists. Design, synthesis and biological evaluation. European Journal of Medicinal Chemistry 2016;124:63
    https://doi.org/10.1016/j.ejmech.2016.08.016
  10. Rajiv Radhakrishnan, David Matuskey, Nabeel Nabulsi, Edward Gaiser, Jean-Dominique Gallezot, Shannan Henry, Beata Planeta, Shu-fei Lin, Jim Ropchan, Yiyun Huang, Richard E Carson, Deepak Cyril D'Souza. In vivo 5-HT6 and 5-HT2A receptor availability in antipsychotic treated schizophrenia patients vs. unmedicated healthy humans measured with [11C]GSK215083 PET. Psychiatry Research: Neuroimaging 2020;295:111007
    https://doi.org/10.1016/j.pscychresns.2019.111007
  11. Alfredo Meneses. Identification of Neural Markers Accompanying Memory. 2020.
    https://doi.org/10.1016/B978-0-12-408139-0.00002-X
  12. Wesam Ali, Małgorzata Więcek, Dorota Łażewska, Rafał Kurczab, Magdalena Jastrzębska-Więsek, Grzegorz Satała, Katarzyna Kucwaj-Brysz, Annamaria Lubelska, Monika Głuch-Lutwin, Barbara Mordyl, Agata Siwek, Muhammad Jawad Nasim, Anna Partyka, Sylwia Sudoł, Gniewomir Latacz, Anna Wesołowska, Katarzyna Kieć-Kononowicz, Jadwiga Handzlik. Synthesis and computer-aided SAR studies for derivatives of phenoxyalkyl-1,3,5-triazine as the new potent ligands for serotonin receptors 5-HT6. European Journal of Medicinal Chemistry 2019;178:740
    https://doi.org/10.1016/j.ejmech.2019.06.022
  13. Gonzalo Vera, Carlos Lagos, Sebastián Almendras, Dan Hebel, Francisco Flores, Gissella Valle-Corvalán, C. Pessoa-Mahana, Jaime Mella-Raipán, Rodrigo Montecinos, Gonzalo Recabarren-Gajardo. Extended N-Arylsulfonylindoles as 5-HT6 Receptor Antagonists: Design, Synthesis & Biological Evaluation. Molecules 2016;21:1070
    https://doi.org/10.3390/molecules21081070
  14. Hyung-Mun Yun, Kyung-Ran Park, Jin Tae Hong, Eun-Cheol Kim. Peripheral serotonin-mediated system suppresses bone development and regeneration via serotonin 6 G-protein-coupled receptor. Sci Rep 2016;6
    https://doi.org/10.1038/srep30985
  15. Coralie Berthoux, Al Mahdy Hamieh, Angelina Rogliardo, Emilie L Doucet, Camille Coudert, Fabrice Ango, Katarzyna Grychowska, Séverine Chaumont‐Dubel, Pawel Zajdel, Rafael Maldonado, Joël Bockaert, Philippe Marin, Carine Bécamel. Early 5‐ HT 6 receptor blockade prevents symptom onset in a model of adolescent cannabis abuse . EMBO Mol Med 2020;12
    https://doi.org/10.15252/emmm.201910605
  16. Scheila Daiane Schmidt, Carolina Garrido Zinn, Lorena Evelyn Cavalcante, Flávia Fagundes Ferreira, Cristiane Regina Guerino Furini, Ivan Izquierdo, Jociane de Carvalho Myskiw. Participation of Hippocampal 5-HT5A, 5-HT6 and 5-HT7 Serotonin Receptors on the Consolidation of Social Recognition Memory. Neuroscience 2022;497:171
    https://doi.org/10.1016/j.neuroscience.2022.06.016
  17. Amanda Alves Marcelino da Silva, Mayara Matias Oliveira, Taisy Cinthia Ferro Cavalcante, Larissa Cavalcanti do Amaral Almeida, Paula Luiza Menezes Cruz, Sandra Lopes de Souza. Undernutrition during pregnancy and lactation increases the number of fos-cells in the reward system in response to a 5-HT6 receptor agonist in male adolescent rats. International Journal of Food Sciences and Nutrition 2018;69:488
    https://doi.org/10.1080/09637486.2017.1382455
  18. Matthew N. McCarroll, Leo Gendelev, Reid Kinser, Jack Taylor, Giancarlo Bruni, Douglas Myers-Turnbull, Cole Helsell, Amanda Carbajal, Capria Rinaldi, Hye Jin Kang, Jung Ho Gong, Jason K. Sello, Susumu Tomita, Randall T. Peterson, Michael J. Keiser, David Kokel. Zebrafish behavioural profiling identifies GABA and serotonin receptor ligands related to sedation and paradoxical excitation. Nat Commun 2019;10
    https://doi.org/10.1038/s41467-019-11936-w
  19. Michał Gałęzowski, Charles-Henry Fabritius, Ullamari Pesonen, Harri Salo, Marta Olszak-Płachta, Klaudia Czerwińska, Justyna Adamczyk, Marcin Król, Peteris Prusis, Magdalena Sieprawska-Lupa, Maciej Mikulski, Katja Kuokkanen, Radosław Obuchowicz, Timo Korjamo, Niina Jalava, Agnieszka Nikiforuk, Mateusz Nowak. 5-HT6 receptor antagonists. Design, synthesis, and structure–activity relationship of substituted 2-(1-methyl-4-piperazinyl)pyridines. Bioorganic & Medicinal Chemistry Letters 2023;96:129497
    https://doi.org/10.1016/j.bmcl.2023.129497
  20. Georg A. Petroianu, Dietrich E. Lorke. The Role of Serotonin in Singultus: A Review. Front. Neurosci. 2020;14
    https://doi.org/10.3389/fnins.2020.00629
  21. Tomasz Wichur, Anna Pasieka, Justyna Godyń, Dawid Panek, Izabella Góral, Gniewomir Latacz, Ewelina Honkisz-Orzechowska, Adam Bucki, Agata Siwek, Monika Głuch-Lutwin, Damijan Knez, Xavier Brazzolotto, Stanislav Gobec, Marcin Kołaczkowski, Raimon Sabate, Barbara Malawska, Anna Więckowska. Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT6 receptor with anti-aggregation properties against amyloid-beta and tau. European Journal of Medicinal Chemistry 2021;225:113783
    https://doi.org/10.1016/j.ejmech.2021.113783
  22. Shujie Wang, Anlin Zhu, Suresh Paudel, Choon-Gon Jang, Yong Sup Lee, Kyeong-Man Kim. Structure–Activity Relationship and Evaluation of Phenethylamine and Tryptamine Derivatives for Affinity towards 5-Hydroxytryptamine Type 2A Receptor. Biomol Ther (Seoul) 2023;31:176
    https://doi.org/10.4062/biomolther.2022.096
  23. A V Ivachtchenko. Sulfonyl-containing modulators of serotonin 5-HT6receptors and their pharmacophore models. Russ. Chem. Rev. 2014;83:439
    https://doi.org/10.1070/RC2014v083n05ABEH004371
  24. Yu-Ming Zhang, Li Zhang, Yong Wang, Yi-Na Sun, Yuan Guo, Cheng-Xue Du, Jin Zhang, Lu Yao, Shu-Qi Yu, Jian Liu. Activation and blockade of prelimbic 5-HT6 receptors produce different effects on depressive-like behaviors in unilateral 6-hydroxydopamine-induced Parkinson's rats. Neuropharmacology 2016;110:25
    https://doi.org/10.1016/j.neuropharm.2016.07.014
  25. Ansab Akhtar, Siddharth Singh, Ravinder Kaushik, Rajendra Awasthi, Tapan Behl. Types of memory, dementia, Alzheimer’s disease, and their various pathological cascades as targets for potential pharmacological drugs. Ageing Research Reviews 2024;96:102289
    https://doi.org/10.1016/j.arr.2024.102289
  26. Tatyana Strekalova, Nataliia Bahzenova, Alexander Trofimov, Angelika G. Schmitt-Böhrer, Nataliia Markova, Vladimir Grigoriev, Vladimir Zamoyski, Tatiana Serkova, Olga Redkozubova, Daria Vinogradova, Alexei Umriukhin, Vladimir Fisenko, Christina Lillesaar, Elena Shevtsova, Vladimir Sokolov, Alexey Aksinenko, Klaus-Peter Lesch, Sergey Bachurin. Pro-neurogenic, Memory-Enhancing and Anti-stress Effects of DF302, a Novel Fluorine Gamma-Carboline Derivative with Multi-target Mechanism of Action. Mol Neurobiol 2018;55:335
    https://doi.org/10.1007/s12035-017-0745-6
  27. Charles C. J. Loh, Gerhard Raabe, Dieter Enders. Enantioselective Synthesis of Tetrahydrocarbazoles through a Michael Addition/Ciamician–Plancher Rearrangement Sequence: Asymmetric Synthesis of a Potent Constrained Analogue of MS‐245. Chemistry A European J 2012;18:13250
    https://doi.org/10.1002/chem.201202908
  28. Nina K. Popova, Vladimir S. Naumenko. Neuronal and behavioral plasticity: the role of serotonin and BDNF systems tandem. Expert Opinion on Therapeutic Targets 2019;23:227
    https://doi.org/10.1080/14728222.2019.1572747
  29. Dool-Ri Oh, Chulyung Choi, Moon Jong Kim, Bo Yeong Mun, Haeju Ko, Kyo-Nyeo Oh, Ara Jo, Jin Young Kim, Donghyuck Bae. Antidepressant effects of p-coumaric acid isolated from Vaccinium bracteatum leaves extract on chronic restraint stress mouse model and antagonism of serotonin 6 receptor in vitro. Phytomedicine 2023;116:154871
    https://doi.org/10.1016/j.phymed.2023.154871
  30. Francesco Panza, Davide Seripa, Madia Lozupone, Vincenzo Solfrizzi, Bruno P. Imbimbo, Maria Rosaria Barulli, Rosanna Tortelli, Rosa Capozzo, Paola Bisceglia, Andrea Dimitri, Roberta Stallone, Vittorio Dibello, Nicola Quaranta, Antonio Daniele, Antonello Bellomo, Antonio Greco, Giancarlo Logroscino. The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset. Expert Opinion on Biological Therapy 2018;18:25
    https://doi.org/10.1080/14712598.2018.1389885
  31. R.V. Lutsenko. CURRENT UNDERSTANDING OF THE ROLE OF THE MONOAMINERGIC NEUROTRANSMITTER SYSTEM IN ANXIOGENESIS. Med. and Ecol. probl. 2022;26:47
    https://doi.org/10.31718/mep.2022.26.5-6.09
  32. Francesco Panza, Davide Seripa, Vincenzo Solfrizzi, Bruno P. Imbimbo, Madia Lozupone, Antonio Leo, Rodolfo Sardone, Gaetano Gagliardi, Lucia Lofano, Bianca C. Creanza, Paola Bisceglia, Antonio Daniele, Antonello Bellomo, Antonio Greco, Giancarlo Logroscino. Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients. Expert Opinion on Emerging Drugs 2016;21:377
    https://doi.org/10.1080/14728214.2016.1241232
  33. Charlotte Uldahl Jansen, Katrine M. Qvortrup. Serotonin and the CNS - New Developments in Pharmacology and Therapeutics. 2016.
    https://doi.org/10.5772/intechopen.96381
  34. Etsay Weldekidan Tsegay, Desalegn Getnet Demise, Nigus Alemu Hailu, Zenawi Hagos Gufue.

    Serotonin Type 6 and 7 Receptors as a Novel Therapeutic Target for the Treatment of Schizophrenia

    . NDT 2020;Volume 16:2499
    https://doi.org/10.2147/NDT.S263424
  35. Joon W. Shim, Todd R. Dodge, Max A. Hammond, Joseph M. Wallace, Feng C. Zhou, Hiroki Yokota, Enrique Hernandez-Lemus. Physical Weight Loading Induces Expression of Tryptophan Hydroxylase 2 in the Brain Stem. PLoS ONE 2014;9:e85095
    https://doi.org/10.1371/journal.pone.0085095
  36. Soon-Hee Kim, Dong Hyuk Kim, Kang Ho Lee, Sun-Kyoung Im, Eun-Mi Hur, Kwang Chul Chung, Hyewhon Rhim, Per Svenningsson. Direct Interaction and Functional Coupling between Human 5-HT6 Receptor and the Light Chain 1 Subunit of the Microtubule-Associated Protein 1B (MAP1B-LC1). PLoS ONE 2014;9:e91402
    https://doi.org/10.1371/journal.pone.0091402
  37. Diego Alejandro Rodríguez-Soacha, Matthias Scheiner, Michael Decker. Multi-target-directed-ligands acting as enzyme inhibitors and receptor ligands. European Journal of Medicinal Chemistry 2019;180:690
    https://doi.org/10.1016/j.ejmech.2019.07.040
  38. John O. Ogbodo, Chinazom P. Agbo, Ugochi O. Njoku, Martins O. Ogugofor, Simeon I. Egba, Stella A. Ihim, Adaeze C. Echezona, Kenneth C. Brendan, Aman B. Upaganlawar, Chandrashekhar D. Upasani. Alzheimer’s Disease: Pathogenesis and Therapeutic Interventions. CAS 2022;15:2
    https://doi.org/10.2174/1874609814666210302085232
  39. Emilie Doucet, Katarzyna Grychowska, Pawel Zajdel, Joël Bockaert, Philippe Marin, Carine Bécamel. Blockade of Serotonin 5-HT6 Receptor Constitutive Activity Alleviates Cognitive Deficits in a Preclinical Model of Neurofibromatosis Type 1. IJMS 2021;22:10178
    https://doi.org/10.3390/ijms221810178
  40. Kun-Cheng Liu, Jun-Yi Li, Hui-Hui Tan, Cheng-Xue Du, Wen Xie, Yu-Ming Zhang, Wei-Lin Ma, Li Zhang. Serotonin6 receptors in the dorsal hippocampus regulate depressive-like behaviors in unilateral 6-hydroxydopamine-lesioned Parkinson's rats. Neuropharmacology 2015;95:290
    https://doi.org/10.1016/j.neuropharm.2015.03.031
  41. Rajiv Radhakrishnan, Nabeel Nabulsi, Edward Gaiser, Jean-Dominique Gallezot, Shannan Henry, Beata Planeta, Shu-fei Lin, Jim Ropchan, Wendol Williams, Evan Morris, Deepak Cyril D’Souza, Yiyun Huang, Richard E. Carson, David Matuskey. Age-Related Change in 5-HT6 Receptor Availability in Healthy Male Volunteers Measured with 11C-GSK215083 PET. J Nucl Med 2018;59:1445
    https://doi.org/10.2967/jnumed.117.206516
  42. Jaime Mella, Francisco Villegas, César Morales-Verdejo, Carlos F. Lagos, Gonzalo Recabarren-Gajardo. Structure-activity relationships studies on weakly basic N -arylsulfonylindoles with an antagonistic profile in the 5-HT 6 receptor. Journal of Molecular Structure 2017;1139:362
    https://doi.org/10.1016/j.molstruc.2017.03.067
  43. Ádám A. Kelemen, Stefan Mordalski, Andrzej J. Bojarski, György M. Keserű. Computational Modeling of Drugs Against Alzheimer’s Disease. 2017.
    https://doi.org/10.1007/978-1-4939-7404-7_15
  44. Nasrin Hashemi-Firouzi, Siamak Shahidi, Sara Soleimani-Asl, Alireza Komaki. 5-Hydroxytryptamine receptor 6 antagonist, SB258585 exerts neuroprotection in a rat model of Streptozotocin-induced Alzheimer’s disease. Metab Brain Dis 2018;33:1243
    https://doi.org/10.1007/s11011-018-0228-0
  45. Annamaria Lubelska, Gniewomir Latacz, Magdalena Jastrzębska-Więsek, Magdalena Kotańska, Rafał Kurczab, Anna Partyka, Małgorzata Anna Marć, Daria Wilczyńska, Agata Doroz-Płonka, Dorota Łażewska, Anna Wesołowska, Katarzyna Kieć-Kononowicz, Jadwiga Handzlik. Are the Hydantoin-1,3,5-triazine 5-HT6R Ligands a Hope to a Find New Procognitive and Anti-Obesity Drug? Considerations Based on Primary In Vivo Assays and ADME-Tox Profile In Vitro. Molecules 2019;24:4472
    https://doi.org/10.3390/molecules24244472
  46. Hue Yu Wang, Cheng Wei Lu, Tzu Yu Lin, Jinn Rung Kuo, Su Jane Wang. WAY208466 inhibits glutamate release at hippocampal nerve terminals. European Journal of Pharmacology 2016;781:117
    https://doi.org/10.1016/j.ejphar.2016.04.010
  47. Ansoo Lee, Hyunah Choo, Byungsun Jeon. Serotonin Receptors as Therapeutic Targets for Autism Spectrum Disorder Treatment. IJMS 2022;23:6515
    https://doi.org/10.3390/ijms23126515
  48. Felicia Phei Lin Lim, Anton V. Dolzhenko. 1,3,5-Triazine-based analogues of purine: From isosteres to privileged scaffolds in medicinal chemistry. European Journal of Medicinal Chemistry 2014;85:371
    https://doi.org/10.1016/j.ejmech.2014.07.112
  49. Matthew Brodsky, Adam J. Lesiak, Alex Croicu, Nathalie Cohenca, Jane M. Sullivan, John F. Neumaier. 5-HT 6 receptor blockade regulates primary cilia morphology in striatal neurons. Brain Research 2017;1660:10
    https://doi.org/10.1016/j.brainres.2017.01.010
  50. Sven Melker Hagsäter, Alexander Lisinski, Elias Eriksson. 5-HT6 receptor antagonism reduces defecation in rat: A potential treatment strategy for irritable bowel syndrome with diarrhea. European Journal of Pharmacology 2019;864:172718
    https://doi.org/10.1016/j.ejphar.2019.172718
  51. Anna Gorlova, Dmitrii Pavlov, Daniel C. Anthony, Eugene D. Ponomarev, Margaux Sambon, Andrey Proshin, Igor Shafarevich, Diana Babaevskaya, Klaus-Peter Lesсh, Lucien Bettendorff, Tatyana Strekalova. Thiamine and benfotiamine counteract ultrasound-induced aggression, normalize AMPA receptor expression and plasticity markers, and reduce oxidative stress in mice. Neuropharmacology 2019;156:107543
    https://doi.org/10.1016/j.neuropharm.2019.02.025
  52. Arzoo Pannu, Ramesh K. Goyal. Serotonin and Depression: Scrutiny of New Targets for Future Anti- Depressant Drug Development. CDT 2023;24:816
    https://doi.org/10.2174/1389450124666230425233727
  53. Mubashir Hassan, Qamar Abbas, Sung‑Yum Seo, Saba Shahzadi, Hany Al Ashwal, Nazar Zaki, Zeeshan Iqbal, Ahmed Moustafa. Computational modeling and biomarker studies of pharmacological treatment of Alzheimer's disease (Review). Mol Med Report 2018
    https://doi.org/10.3892/mmr.2018.9044